Amazon, Alphabet And A Pharmaceutical Giant: CNBC’s ‘Final Trades’

On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said Amazon.com, Inc. (NASDAQ: AMZN) is on the 

On CNBC’s “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners said Amazon.com, Inc. (NASDAQ:AMZN) is on the cusp of an all-time high.

Amazon.com is restarting construction of a 42-story office tower in Bellevue, a Seattle suburb, after halting work on 22 floors since 2022. The pause in 2022 affected five towers in Bellevue and new offices in Virginia and Nashville as Amazon evaluated the pandemic’s impact on in-office work dynamics.

Stephen Weiss of Short Hills Capital Partners said Alphabet Inc. (NASDAQ:GOOG) (NASDAQ:GOOGL) has got a long way to go.

Alphabet has once again secured the top position in the list of “America’s Most Innovative Companies 2024,” despite facing internal criticism and AI-related challenges. Last month, Fortune and Statista revealed that Alphabet has maintained its leading position for the second consecutive year. This is despite the company’s internal turmoil and AI-related issues.

Don’t forget to check out our premarket coverage here

Jenny Van Leeuwen Harrington of Gilman Hill Asset Management, LLC said Pfizer Inc. (NYSE:PFE) has a 6.3% dividend yield.

On April 5, Cantor Fitzgerald analyst Louise Chen reiterated Pfizer with an Overweight and maintained a $45 price target.

Price Action:

  • Amazon shares gained 2.8% to close at $185.07 on Friday.
  • Alphabet shares gained 1.3% to settle at $153.94 on Friday.
  • Pfizer shares rose 0.04% to settle at $26.66 during Friday’s session.

Check This Out: Jim Cramer Says ‘Nothing Terrific’ About GitLab, But Rocket? Time To ‘Ka-Ching, Ka-Ching’

Total
0
Shares
Related Posts
Read More

Check Point Software Garners Cautious Optimism From Analysts: Solid Revenue Growth Clashes With Market Share Concerns

Mizuho analyst maintains Check Point Software with Neutral rating and raises price target. Q4 revenue grows 4%, subscriptions up 15%, operating margins beat expectations. 2024 outlook positive, CEO succession plan announced. Wedbush and Truist raise price targets, Susquehanna and KeyBanc maintain ratings.

CHKP